Please Wait...

Research Network Global Sites

Structured to optimize the conduct of clinical research.

With a geographic spread throughout the U.S., Europe, Latin America, and Asia, the Bioclinica Research Network brings you the most diverse standardized global site network in the industry. Additionally, we provide a cross-continent, cross-season advantage by being in both the northern and southern hemispheres.

EACH OF OUR RESEARCH SITES IS:

  • Structured and centrally managed to optimize the conduct of clinical research
  • Strategically located to take advantage of access to patient populations
  • Outfitted with state-of-the-art medical testing equipment
  • Staffed by physicians, nurses, study coordinators, technicians and other medical professionals and personnel with therapeutic area specialization
 

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support you.

CONTACT US Download Brochure

TECHNOLOGY AND EQUIPMENT

Our innovative technologies enable us to reduce trial complexity, increase efficiency, and provide greater clarity around the effects of the drug being researched so that you can achieve your scientific and business objectives as swiftly as possible.

All our facilities have access to the equipment needed to run various tests, including imaging equipment, MRIs, PET scanners, etc.

DEDICATED SMO SERVICE IN CHINA

The Bioclinica Research Network partners with multiple hospitals in China, operating under Bioclinica's patient and project management, SOPs, and quality assurance (QA). Additionally, Bioclinica has an agreement with several hospitals including Peking University Cardiology Department and Beijing Anzhen Cardiology Department to conduct clinical research.

BIOCLINICA RESEARCH NETWORK BY THE NUMBERS

  • 30+ dedicated research centers in 14 countries across 4 continents
  • Clinics range in size from 600 m2 to 3000 m2 (2000-6500 square feet)
  • Local population covered by a site varies from 300,000 to 20+ million
  • 25,000 patient spaces across the global network
  • Site capacity ranges from 800 to 2500 subjects annually
  • Daily site capacity range 50-125 visits per day
  • Total number of employees is approximately 975
  • Proprietary database of >300,000 patients
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Handy guide for the pharmacovigilance folks! https://t.co/tOyQWkiNhW
bioclinica (Yesterday)
#ClinicalResearch sites, REJOICE @bioclinica SMART Submit 4 cloud rsch image mgmt /subm is here! @OutsourcPharmahttp://ow.ly/odCh30grhnY
bioclinica (Yesterday)
What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (2 days ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (3 days ago)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (3 days ago)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (3 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices